Aurora Cannabis Inc.
ACB • NASDAQ
Aurora Cannabis Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Miguel Martin, with a market cap of $181.5M.
CEOMiguel Martin
Next Earnings
Upcoming earnings announcement for Aurora Cannabis Inc.
Date
Wednesday, June 17, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q4 2026
EPS Estimate
-$0.07
Revenue Estimate
$55.3M
Earnings History
Past 12 earnings reports for Aurora Cannabis Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 4, 2026 | Q3 2026 | $0.02Est: $0.19 | -88.9% | $67.6MEst: $65.9M | +2.5% | — |
| Nov 5, 2025 | Q2 2026 | -$0.19Est: $0.02 | -1050.0% | $65.6MEst: $63.8M | +2.9% | — |
| Aug 6, 2025 | Q1 2026 | -$0.19Est: $0.18 | -205.6% | $70.8MEst: $70.9M | -0.1% | — |
| Jun 18, 2025 | Q4 2025 | -$0.24Est: $0.11 | -318.2% | $63.1MEst: $62.0M | +1.7% | — |
| Feb 5, 2025 | Q3 2025 | $0.41Est: $0.04 | +925.0% | $63.1MEst: $57.6M | +9.5% | — |
| Nov 6, 2024 | Q2 2025 | $0.04Est: -$0.21 | +119.0% | $59.5MEst: $50.4M | +17.9% | — |
| Aug 7, 2024 | Q1 2025 | $0.09Est: -$0.35 | +125.7% | $61.0MEst: $57.2M | +6.7% | — |
| Jun 20, 2024 | Q4 2024 | -$0.30Est: -$0.17 | -76.5% | $50.0MEst: $51.4M | -2.7% | — |
| Feb 8, 2024 | Q3 2024 | -$0.40Est: -$0.10 | -300.0% | $47.3MEst: $46.9M | +1.0% | — |
| Nov 9, 2023 | Q2 2024 | $0.10Est: -$0.30 | +133.3% | $47.3MEst: $45.0M | +5.0% | — |
| Aug 10, 2023 | Q1 2024 | -$0.44Est: -$0.80 | +45.0% | $55.9MEst: $46.8M | +19.5% | — |
| Jun 14, 2023 | Q3 2023 | -$1.80Est: -$0.50 | -260.0% | $47.3MEst: $48.7M | -2.8% | — |